FEDERAL COURT OF AUSTRALIA
Australian Competition and Consumer Commission v Medibank Private Limited [2020] FCA 1030
Keep reading for free
Create a free CaseChat account to read Australian Competition and Consumer Commission v Medibank Pr... and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2020] FCA 1030
- Decision Date
CaseChat Overview and Summary
The court considered the principles relevant to the making of consent orders in a civil penalty proceeding, including the public interest in the settlement of cases, the need for the orders to be consistent with the public interest, and the need for the court to exercise a degree of restraint when scrutinising the proposed settlement terms. The court also considered the mandatory statutory factors relevant to the assessment of the appropriate penalty, including the nature, extent, and duration of the contravening conduct, the loss and damage to consumers, and the deterrence effect of the penalty. The court concluded that a penalty of $5 million was appropriate, taking into account the totality of the contravening conduct, the loss and damage to consumers, and the deterrence effect of the penalty. The court also ordered Medibank to pay $70,000 towards the ACCC's costs and dismissed the proceeding otherwise.
Orders
Orders of the court
2. Pursuant to section 224 of the ACL, Medibank pay to the Commonwealth of Australia a pecuniary penalty in the sum of $5,000,000 in respect of the contraventions referred to in the declaration in paragraph 1 of these orders, to be paid within 60 days of the date of 16 July 2020.
3. Medibank make a contribution to the ACCC's costs in the amount of $70,000 to be paid within 60 days of the date of 16 July 2020.
4. The proceeding be otherwise dismissed.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
In these circumstances, I turn to consider the particular factors relevant to the assessment of whether the proposed penalty is, in the circumstances of the admitted facts, an appropriate penalty to achieve that deterrent effect including by reference to the mandatory statutory factors which I consider further below.Nature, extent and duration of contravening conduct and circumstances in which it took place The parties jointly submitted, and I accept, that the contravening conduct was serious. The admitted conduct involved Representations about the benefits payable to Affected Members under the Policies, including for procedures under the Lite Policies such as tendon or ligament transfers, microsurgical discectomy of intervertebral disc or discs or tendon repair: SOAFA [18]. The admitted conduct involved approximately 1,396 Representations: SOAFA [36]. The admitted conduct in respect of the Lite Policies also continued over a five-year period and the conduct in respect of the Boost Policies for over a year: SOAFA [6] and [28]. The contravening conduct continued after Medibank became aware of it, for over a year in respect of the Lite Policies, and for almost six months in respect of the Boost Policies. The conduct affected approximately 849 Affected Members: 843 under the Lite Policies, two under the Boost Policies and four Affected Members who held both Boost Policies and Lite Policies: SOAFA [36]. As I have stated above, while the conduct continued for over a year in respect of the Lite Polices, when the issue was first identified, Medibank implemented some measures in an attempt to contain it. It was jointly submitted and I accept that: (1)the Affected Members were misled about the benefits to which they were in fact entitled, and denied the opportunity to make informed decisions about their medical procedures, medical treatment and health insurance coverage. In some cases, Affected Members incurred significant out of pocket expenses, or experienced pain and suffering as a result of delaying medical procedures and treatment: SOAFA [45] and [46]; (2)the contravening conduct concerns the core of Medibank's business, being the provision of benefits to Members under health insurance policies; and(3)Medibank initially took some steps to address the contravening conduct, but its systems and processes were not sufficiently adequate to identify the extent of the contravening conduct and to address it promptly.Loss and damage to consumers The loss and damage to consumers reflects the nature of the contravening conduct: (1)as a consequence of the admitted contravening conduct, Affected Members incurred out of pocket expenses. This included for some Affected Members significant out of pocket expenses for major procedures. As at April 2019, the average amount of compensation paid by Medibank to 95 Affected Members pursuant to its voluntary remediation program was approximately $3,630: SOAFA [47]. At least 48 Affected Members upgraded their policy to a more expensive policy to obtain benefits to which they were in fact already entitled – at an average cost of approximately $704 with expenses ranging from $29 up to $3,551: SOAFA [43];(2)Affected Members as a result of the admitted contravening conduct were denied the opportunity to make properly informed decisions about proceeding with a Joint Procedure. They were also denied the opportunity of making properly informed decisions about whether to change providers or increase their level of health insurance cover with ahm; (3)another consequence of the admitted contraventions was that some Affected Members elected to delay surgery or not to undertake surgery. In some cases, Affected Members who upgraded their cover with ahm or with an alternative insurer were required to serve waiting periods of up to 12 months for the relevant procedure.